Proteomics Market

Proteomics Market Outlook (2024 to 2034)

Projected to expand at a CAGR of 16.6%, the global proteomics market is expected to swiftly increase from a valuation of US$ 41.9 million in 2024 to US$ 194.6 million by the end of 2034.

The market is benefiting as the understanding of protein cells is emerging as an important field of study in healthcare. Proteomics involves the study of interactions, functions, composition, and structures of proteins and their cellular activities. Proteomics provides a deeper understanding of the structure and function of an organism than genomics.

Proteins are the fundamental cells, and to prevent the spread of diseases, doctors must understand the functionality of these protein cells. After the COVID-19 pandemic, governments across the world have begun investing in proteomics to ensure readiness for any medical emergencies.

Primary purpose of proteomics is to detect protein expression patterns at a given time in response to a specific stimulus and determine functional protein networks that exist at the level of the cell, or whole organism. The proteomics market is projected to grow at a significant rate as scientists understand the human body more vividly and help prevent the spread of any disease on a large scale.

Key Market Growth Drivers

• Proteomics technologies efficiently identify, characterize, and quantify allergen proteins, contributing to allergen detection and control strategies. This has significantly impacted scientists in food technology.
• Proteomics can be used to develop a protein-network map, determining protein interactions within a living system in detail.
• In the medical industry, proteomics reveals changes in protein composition and abundance under diseased or stressed conditions, aiding in the development of treatments to counter such changes. This has led to advancements in treatments, thus boosting the demand for proteomics solutions.
• Similarly, the agricultural industry uses proteomics to study the molecular basis of stress adaptation and tolerance, leading to the development of crop varieties resilient to poor soil, high temperatures, and low water availability. This has boosted farmers' profits and improved vegetation success rates.
• Emerging techniques such as mass spectrometry, protein pathway arrays, and nanopore-based single-molecule proteomics have transformed the market, attracting more investors and scientists to contribute their expertise and time.
• Proteomics is extensively used in the animal industry to understand intestinal and respiratory diseases as well as parasite pathogenesis. This technique has been saving several animal lives, making it popular among animal lovers and contributing significantly to the expansion of the proteomics market size.

Report Attribute	Detail
Proteomics Market Size (2024E)	US$ 41.9 Million
Forecasted Market Value (2034F)	US$ 194.6 Million
Global Market Growth Rate (2024 to 2034)	16.6% CAGR
Canada Market Growth Rate (2024 to 2034)	17% CAGR
China Market Value (2034F)	US$ 16 Million
North America Market Share (2024E)	36.8%
East Asia Market Share (2034F)	20%
Key Companies Profiled	Agilent Technologies; Bruker; Thermo Fisher Scientific; Merck KGaA; GE HealthCare; PerkinElmer; Biognosys AG; Charles River Laboratories; Horiba; Danaher Corporation; Carpicon Proteomics Inc.; Luminex Corporation; Waters Corporation; Bio-Rad Laboratories; Promega Corporation.

Which Proteomics Market Trends are Proving Beneficial for Market Players?

“Growing Demand for Personalized Medicine and Rising Burden of Genetic Disorders”

Growth of the market is being propelled by the demand for personalized medicine, technological advancements, and innovation, alongside increased funding opportunities from both public and private sectors. Given the rapid expansion of the pharmaceutical and biopharmaceutical fields, the demand for proteomics has increased. The global market is projected to exhibit significant expansion in the coming decades due to a heightened need for customized medication and the rising costs associated with genetic illnesses.

Another factor projected to fuel market growth is the rising prevalence of chronic diseases such as cancer, cardiovascular diseases (CVDs), respiratory diseases, CKD, and other ailments.

• Globocan data reveals that in December 2020, there were 19.3 million new cancer cases and 10 million cancer-related deaths worldwide. Similarly, cardiovascular diseases rank among the primary causes of mortality globally.

“Focus on Refining Sample Preparation and Fractionation Techniques”

Modern advancements in technology have revolutionized proteomics, enhancing sensitivity and resolution, enabling high throughput and multiplexed analysis, refining sample preparation and fractionation techniques, facilitating mass spectrometry-based imaging, and providing advanced data analysis tools. These advancements have deepened the understanding of the proteome, accelerating biomarker discovery, personalized medicine, and drug development.

Recent technological breakthroughs have broadened the scope of proteomics research, allowing for a more comprehensive exploration of proteins across various biological contexts. Progress in protein function, disease mechanisms, drug discovery, and personalized medicine has been the driving force behind this growth.

“Governmental Backing for Proteomics Research and Applications”

Advancements in proteomic technologies and methodologies in the Asia Pacific region are driving market growth. Researchers in this region utilize advanced techniques such as mass spectrometry, protein profiling, and protein interaction analysis to investigate complex biological systems.

Availability of sophisticated proteomics platforms and instruments has stimulated the expansion of proteomics research and applications. Governments in the Asia Pacific region are actively supporting scientific research and innovation, including in proteomics.

Initiatives such as research grants, funding programs, and regulatory frameworks bolster proteomics research and its applications. This governmental backing has cultivated a conducive environment for proteomics development in the region. With competition intensifying in developed countries, market players are redirecting their attention to developing countries for stability.

What are the Hindrances to Global Market Growth?

“Lack of Data Management Capabilities and High Cost of Instruments”

Proteomics research is used to discover new drugs, vaccines, and diagnostic targets, as well as characterize protein-based products, conduct toxicology studies, and identify surrogate markers of activity in clinical research to understand drug mechanisms. Protein analytics can be costly due to the need for various platforms, instruments, documentation systems, software, and databases in the lab.

Proteomics experiments require specialized expertise for sample preparation, data analysis, and interpretation. This expertise can be difficult and expensive to obtain, especially for smaller organizations. High instrument costs can limit market growth. Limited adoption due to cost constraints may slow market expansion.

As proteome analysis deepens, the volume of data generated is projected to increase. Managing and processing proteomics data requires specialized expertise, resources, and infrastructure. Addressing these challenges is critical to the advancement of proteomics research.

Country-wise Evaluation

The market in Japan is projected to expand at a CAGR of 18.3% from 2024 to 2034, and the country is projected to occupy a proteomics market share of 52.6% by 2034 in the East Asia region.

Why is the United States a Lucrative Market for Proteomics Researchers?

“High Demand for High-quality Research Equipment”

Attribute	United States
Market Value (2024E)	US$ 13 Million
Growth Rate (2024 to 2034)	16.6% CAGR
Projected Value (2034F)	US$ 61 Million

Advancement of proteomics research, the demand for high-quality research equipment to ensure data reproducibility, and the emphasis on personalized treatment development have all contributed to the prominence of the field in the United States. Collaborations and agreements among major players in the country are also fueling market growth.

• A prime example is Symphogen's collaboration with Thermo Fisher Scientific Inc. to develop established platform methods for the rapid characterization and quality control of complex therapeutic proteins.

What is Attracting Proteomics Researchers to China?

“Government Support for Research in Genomics and Proteomics”

Attribute	China
Market Value (2024E)	US$ 3 Million
Growth Rate (2024 to 2034)	18.9% CAGR
Projected Value (2034F)	US$ 16 Million

During the forecast period, the Chinese market is projected to grow at a significant pace due to increased government initiatives to support research and development in genomics, bioinformatics, and proteomics. The government has become cautious after the COVID-19 pandemic to make sure no such medical emergencies occur in the country again, thus driving proteomics market growth.

Category-wise Insights

By end user, the research and academics segment is estimated to hold a market share of 51.5% in 2024.

Which Components are Widely Used by Researchers in Proteomics?

“Ease of Use Associated with Reagents & Kits”

Attribute	Reagents & Kits
Segment Value (2024E)	US$ 21.6 Million
Growth Rate (2024 to 2034)	16.7% CAGR
Projected Value (2034F)	US$ 101.4 Million

Reagents and kits are very helpful in drug testing, as they are simple to use and involve easy procedures. This facilitates the quick formulation of solutions. The segment accounts for more than half of overall product sales and will continue to do so over the next ten years.

How Do Microarray Instruments Contribute to Proteomics Research?

“Microarray Instruments Facilitating Enhanced Replication Capabilities”

Attribute	Microarray Instruments
Segment Value (2024E)	US$ 11.4 Million
Growth Rate (2024 to 2034)	16.6% CAGR
Projected Value (2034F)	US$ 52.9 Million

Microarray instruments facilitate increased replication and provide wider diversity in environmental samples, thus boosting their widespread use in proteomics research. They facilitate easy identification of gene sets linked to metastasis or response to treatment.

Business Rivalry

Key players in the proteomics market are incorporating innovative technologies into their product portfolio. To enhance their sales and expand their market share, companies are pursuing strategies such as collaborations and partnerships and expanding their presence in research into mycoprotein products and plant protein ingredients.

• In November 2022, Danaher announced a strategic partnership with Duke University to establish the first Danaher Beacon for Gene Therapy Innovation.
• In September 2020, Bruker Corporation announced the acquisition of the proteomics search engine Integrated Proteomics Pipeline (IP2).

Fact.MR provides detailed information about the price points of key players in the proteomics market positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.

Key Segments of Proteomics Market Research

• By Component :

  • Instruments
    • Spectrometry
    • Protein Microarray Systems
    • Chromatography Systems
    • Surface Plasmon Resonance
    • Electrophoresis
    • Protein Fractionation Systems
    • X-ray Crystallography
  • Reagents & Kits
    • Protein Microarray Reagents
    • X-Ray Crystallography Reagents
    • Spectroscopy Reagents
    • Chromatography Reagents
    • Electrophoresis Reagents
    • Immunoassay Reagents
    • Protein Fractionation Reagents
  • Core Proteomics Services
    • Protein Identification Services
    • Protein Separation Services

• By Technology :

  • Microarray Instruments
  • X-Ray Crystallography
  • Spectroscopy
  • Chromatography
  • Protein Fractionation Systems
  • Electrophoresis
  • Surface Plasma Resonance Systems

• By Application :

  • Drug Discovery
  • Clinical Diagnosis
  • Cancer Research

• By End User :

  • Contract Research Organizations (CROs)
  • Research & Academic Institutions
  • Pharma & Biotech Companies

• By Region :

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa